Evidence map›Paper›PMID 41807728›Full record

ArticleNature microbiology2026

Conditional activation of Cas13 enforces lysogeny in a native type VI-A CRISPR host.

Marshall Godsil, Nova Wei, Alexander J Meeske

Abstract read
In one paragraph

Article in Nature microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marshall GodsilDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Nova WeiDepartment of Microbiology, University of Washington, Seattle, WA, USA.
Alexander J MeeskeDepartment of Microbiology, University of Washington, Seattle, WA, USA. meeske@uw.edu.ORCID http://orcid.org/0000-0003-3878-531X

Funding

CRISPR-Cas13 immunity in Listeria seeligeriR35GM142460 · NIGMS · UNIVERSITY OF WASHINGTON · PI Alexander Jacob Meeske · 2021 to 2026
$2.7M
Viral Pathogenesis Training ProgramT32AI083203 · NIAID · UNIVERSITY OF WASHINGTON · PI BLOOM, JESSE D, LAGUNOFF, MICHAEL · 2009 to 2023
$2.7M
NIAID NIH HHS T32 AI083203NIGMS NIH HHS R35 GM142460NSF | BIO | Division of Molecular and Cellular Biosciences (MCB) FAIN2235762U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM142460
6 · The paper itself

Abstract

CRISPR-Cas (clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins) systems present a barrier to prophage acquisition by restricting invading phages or by inducing autoimmune cleavage of integrated prophage DNA. The RNA-sensing type VI CRISPR nuclease Cas13 mediates non-specific RNA cleavage upon recognition of phage lytic transcripts, but how this system influences the temperate phage life cycle remains unknown. Here we report that the Listeria seeligeri type VI-A CRISPR system restricts the lytic cycle of temperate phages but tolerates prophage acquisition and interferes with prophage induction through a non-abortive mechanism. During attempts at induction, Cas13 activation forces prophage re-integration, thus maintaining lysogeny. We also find that during polylysogenic induction, Cas13 acts specifically, restricting only the targeted phage, in contrast to its behaviour during lytic replication. Our findings show that Cas13 elicits a unique response to each stage of the temperate phage life cycle, enabling type VI CRISPR hosts to acquire potentially beneficial prophages while mitigating lysis.

Indexed as

CRISPR-Associated ProteinsCRISPR-Cas SystemsLysogenyBacterial ProteinsClustered Regularly Interspaced Short Palindromic RepeatsDNA, ViralListeria monocytogenesProphagesBacterial ProteinsCRISPR-Associated ProteinsDNA, Viral

Identifiers

PMID41807728
PMCPMC13046388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.